|
Mr. Capone joined Progenics in January 2007. His 17 years of US and International commercial leadership experience include Senior Vice President of Commercial Operations at Trimeris Inc. where he managed the FUZEON® and fusion inhibitor commercial collaboration with Hoffman LaRoche. Prior to Trimeris Mr. Capone was Vice President of Marketing and Development at Triangle Pharmaceuticals Inc. where he led the commercial development of HIV hepatitis B and cancer drug candidates. Previous to his experience at Triangle Mr. Capone served as the Director Infectious Diseases and Immunology at Bristol Myers-Squibb managing their portfolio of Antimicrobial Antiviral and Immunological drugs in international markets. Mr. Capone also held marketing and sales management positions in the US and the Netherlands for Lederle Pharmaceuticals now part of Wyeth Inc. He earned his MBA in Finance and International Business from Columbia University School of Business and an undergraduate degree in International Relations from Brown University in Providence Rhode Island. | 